Plasma Distribution of Methotrexate and Its Polyglutamates in Pediatric Acute Lymphoblastic Leukemia: Preliminary Insights

No abstract is available for this paper.

• Publication year

  2021

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  2021-10-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13318-021-00726-9PMID 34637107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanism of action and pharmacokinetic properties of methotrexate

  2020cited by this paper
• Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.

  2019cited by this paper
• The increasing doses of methotrexate pharmacokinetics after intravenous administration in rats - model selection

  2019cited by this paper
• Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.

  2019cited by this paper
• Semisynthetic bile acids: a new therapeutic option for metabolic syndrome.

  2019cited by this paper
• Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

  2018cited by this paper
• Acute Lymphoblastic Leukemia in Children and Adolescents

  2018cited by this paper
• Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression

  2018influential reference
• Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome

  2018cited by this paper
• Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy

  2018cited by this paper
• Acute lymphoblastic leukemia: a comprehensive review and 2017 update

  2017cited by this paper
• Intensive chemotherapy in children with acute lymphoblastic leukemia. Interim analysis in a referral center in Colombia

  2016cited by this paper
• Acute Lymphoblastic Leukemia in Children.

  2015cited by this paper
• Treatment of pediatric acute lymphoblastic leukemia.

  2015cited by this paper
• Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction

  2014cited by this paper
• Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia

  2013cited by this paper
• Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method

  2013cited by this paper
• Acute Lymphoblastic Leukemia in Children

  2013cited by this paper
• Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.

  2012cited by this paper
• A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.

  2012cited by this paper
• Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.

  2011cited by this paper
• Acute lymphoblastic leukemia.

  2011cited by this paper
• The tumor lysis syndrome.

  2011cited by this paper
• PharmGKB summary: methotrexate pathway.

  2011cited by this paper
• Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.

  2010cited by this paper
• Fractional kinetics in multi-compartmental systems

  2010cited by this paper
• The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia

  2010cited by this paper
• A novel high-performance liquid chromatography/mass spectrometry method for improved selective and sensitive measurement of methotrexate polyglutamation status in human red blood cells.

  2009cited by this paper
• Simultaneous determination of methotrexate and its polyglutamate metabolites in Caco-2 cells by liquid chromatography-tandem mass spectrometry.

  2009cited by this paper
• Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.

  2009cited by this paper
• Monoketocholate can decrease transcellular permeation of methotrexate across Caco‐2 cell monolayers and reduce its intestinal absorption in rat

  2009cited by this paper
• Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells

  2008cited by this paper
• Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.

  2007cited by this paper
• High‐Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use?

  2005cited by this paper
• Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

  2005cited by this paper
• The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.

  2005influential reference
• Inhibitory effect of bile salts on the enterohepatic circulation of methotrexate in the unanesthetized rat: Inhibition of methotrexate intestinal absorption

  2004cited by this paper
• Acute lymphoblastic leukemia.

  2004cited by this paper
• The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

  2004cited by this paper
• Toward a better understanding of methotrexate.

  2004cited by this paper
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003influential reference
• HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.

  2003cited by this paper
• Therapeutic drug monitoring of cytotoxic drugs.

  2001cited by this paper
• Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.

  1999cited by this paper
• Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.

  1999cited by this paper
• Time course of methotrexate polyglutamate formation and degradation in the pre-B-leukaemia cell line Nalm6 and in lymphoblasts from children with leukaemia.

  1996cited by this paper
• Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.

  1996cited by this paper
• Acute tumor lysis syndrome after intrathecal methotrexate administration

  1991cited by this paper
• Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis.

  1990cited by this paper
• Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates.

  1986cited by this paper
• Polyglutamation of methotrexate. Is methotrexate a prodrug?

  1985cited by this paper
• Characteristics of methotrexate polyglutamate formation in cultured hepatic cells.

  1982cited by this paper

• Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond.

  2025cites this paper
• Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment

  2025cites this paper
• Gentamicin Release from Hydroxyapatite-based Bioceramic Coating on Titanium

  2025cites this paper
• Methotrexate polyglutamates

  2024cites this paper
• Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response

  2022cites this paper